About the controversies of the cardioprotective effect of n-3 polyunsaturated fatty acids (PUFAs) between animal studies and clinical meta-analyses: a review with several strategies to enhance the beneficial effects of n-3 PUFAs

J Physiol Biochem. 2019 Aug;75(3):241-251. doi: 10.1007/s13105-019-00670-y. Epub 2019 Mar 1.

Abstract

Several meta-analyses describing the effect of n-3 polyunsaturated fatty acids on the survival rate of the victims of an acute coronary event do not clearly support a beneficial impact of these fatty acids. Yet, animal studies consistently show n-3 PUFA-induced protection against ischemia-reperfusion-induced myocardial injuries. The impact on reperfusion arrhythmias of these PUFAs is more controversial. The literature shows the anti-arrhythmic properties of circulating n-3 PUFAs. However, when these fatty acids are incorporated in the cardiac membrane, they protect the myocardial tissue vis a vis cellular damage but they can be either pro- or anti-arrhythmic during reperfusion, depending on the severity of tissue injuries. The latter elements can explain the lack of beneficial effect observed in the meta-analyses, but a proper use of n-3 PUFAs may provide advantages in terms of survival rate. This review discusses the different results obtained in humans and animals and presents several strategies to enhance the beneficial effects of n-3 PUFAs.

Keywords: Arrhythmias; Cardiac death; Cellular damages; Heart; Infarction; N-3 PUFAs.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Arrhythmias, Cardiac / drug therapy*
  • Cardiotonic Agents / pharmacology
  • Fatty Acids, Omega-3 / pharmacology*
  • Heart / drug effects*
  • Humans
  • Meta-Analysis as Topic
  • Mice
  • Myocardial Reperfusion Injury / drug therapy*
  • Myocardium / pathology
  • Rats

Substances

  • Anti-Arrhythmia Agents
  • Cardiotonic Agents
  • Fatty Acids, Omega-3